CardioLogs ECG Analysis Platform vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Bunkerhill Health

AI Verdict

Tool A specializes in the AI-powered analysis of ECG data for arrhythmia detection and diagnosis, making it ideal for managing heart rhythm disorders. In contrast, Tool B focuses on analyzing chest CT scans to detect and quantify coronary artery calcium, aiding in the early identification of atherosclerotic cardiovascular disease risk. While both are FDA-cleared cardiology AI solutions, they address distinct clinical problems using different diagnostic modalities.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid, AI-powered analysis of diverse ECG data for accurate arrhythmia detection and diagnosis. This platform is ideal for cardiologists and emergency medicine physicians who require efficient processing of Holter, smartwatch, or patch ECGs to quickly identify and manage heart rhythm disorders.

View CardioLogs ECG Analysis Platform →

Choose iCAC Device if…

Choose the iCAC Device if you aim to opportunistically identify and quantify coronary artery calcium from routine, non-contrast chest CT scans. This tool is best suited for radiologists and cardiologists seeking to leverage existing imaging data to assess cardiovascular disease risk and aid in early detection, without requiring dedicated cardiac CT scans.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform iCAC Device
Pricing Unknown Contact for pricing
Deployment Cloud-based Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs offers a cloud-based SaaS platform with multi-device compatibility, including smartwatches and ECG patches, and provides real-time monitoring and customizable reports. This broad compatibility and immediate feedback suggest a highly versatile and user-friendly experience for a wider range of clinical workflows compared to iCAC's integration with PACS/DICOM for CT analysis.

Clinical Value

iCAC Device

Both tools are FDA-cleared and offer significant clinical value. However, Bunkerhill Health's iCAC Device provides a unique value proposition by opportunistically detecting and quantifying coronary artery calcium from *routine, non-contrast, non-gated chest CT scans*. This leverages existing data for proactive risk assessment, potentially leading to earlier detection and intervention for cardiovascular disease without additional dedicated procedures.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs offers a transparent 'Pay per ECG regardless of the number of users' pricing model, which allows institutions to predict and manage costs based on actual usage. In contrast, Bunkerhill Health's iCAC Device lists 'contact for pricing' with no further details, making it less transparent and harder to assess the immediate value proposition.

Enterprise Readiness

CardioLogs ECG Analysis Platform

CardioLogs explicitly states it is HIPAA compliant, utilizes ISO/IEC 27001 certified AWS servers for secure hosting, and indicates a Business Associate Agreement (BAA) is likely. While iCAC is FDA-cleared and integrates with EHRs, its BAA and HIPAA compliance details require contacting the vendor, indicating less immediate transparency on these critical enterprise requirements.

Innovation

iCAC Device

Both tools utilize deep learning for medical analysis. However, Bunkerhill Health's iCAC Device demonstrates a higher degree of innovation by enabling the opportunistic identification and quantification of coronary artery calcium from *existing, routine chest CT scans*. This approach maximizes the utility of already collected data for proactive disease detection, offering a scalable solution for population health without requiring new imaging procedures.

Support & Docs

CardioLogs ECG Analysis Platform

CardioLogs explicitly mentions technical support channels accessible via their platform and provides various documentation, including brochures, white papers, and clinical articles. While Bunkerhill Health's Trust Center lists security and compliance reports, it does not offer as explicit or direct information regarding user support and product documentation as CardioLogs.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform iCAC Device
Product Name CardioLogs ECG Analysis Platform iCAC Device
Company Cardiologs Technologies (now part of Philips) Bunkerhill Health
Primary Use Case Rapid, accurate, and efficient analysis of ECG data for arrhythmia detection and diagnosis. Detects and quantifies coronary artery calcium from routine chest CT scans, aiding in early cardiovascular disease detection.
Input Data Type ECG data from various cardiac monitoring devices (Holter, smartwatches, ECG patches) Routine, non-contrast, non-gated chest CT scans
Key AI Functionality AI-Powered ECG Analysis (Deep Neural Networks) for automated arrhythmia detection. Utilizes deep-learning algorithms for analysis to estimate presence and quantity of coronary artery calcium (CAC).
Integration Capabilities Integration with EHR Systems Integrates with PACS or DICOM router. Integrates with EHRs via the Carebricks platform.

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform is designed for rapid, accurate, and efficient analysis of ECG data to aid physicians in arrhythmia detection and diagnosis. The iCAC Device, on the other hand, is an AI algorithm that detects and quantifies coronary artery calcium from routine chest CT scans, assisting in early cardiovascular disease detection.
CardioLogs ECG Analysis Platform analyzes ECG data obtained from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. The iCAC Device specifically analyzes routine, non-contrast, non-gated chest CT scans to identify and quantify coronary artery calcium.
The CardioLogs ECG Analysis Platform is a cloud-based solution that offers integration with EHR systems. The iCAC Device is a Software as a Medical Device (SaMD) that integrates with PACS or a DICOM router and can also integrate with EHRs via the Carebricks platform.
CardioLogs ECG Analysis Platform is primarily intended for use in Cardiology, Emergency Medicine, and Internal Medicine. The iCAC Device is designed to support Cardiology and Radiology specialties.
CardioLogs ECG Analysis Platform is HIPAA compliant, FDA cleared, and uses ISO/IEC 27001 certified AWS servers for data encryption and secure hosting. For the iCAC Device, it is FDA cleared, but details regarding HIPAA compliance and Business Associate Agreements (BAA) require direct contact with the vendor.
CardioLogs ECG Analysis Platform provides AI-powered automated arrhythmia detection, such as AFib and VT, and generates customizable reports from ECG analysis. The iCAC Device estimates the presence and quantity of coronary artery calcium (CAC), provides visual representations of CAC segmentation, and delivers exact and four-category quantitative estimates of CAC burden in Agatston units from CT scans.
AI Tool Finder
AI-powered search. Results may not be comprehensive.